(Reuters) -Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound ...

The cross-reactivity among cephalosporins and between cephalosporins and ... Beall, GN, Rohr, AS, Adelman, DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med ...

The company said there is potential likelihood that a serious anaphylactic reaction in patients, with known hypersensitivity to beta-lactam or penicillin products, could result from receiving these ...

Risk Statement: The potential cross contamination with a non-antibacterial beta-lactam drug substance could lead to hypersensitivity reactions such as swelling, rash, urticaria and anaphylaxis, a ...

Like penicillin, the non-penicillin beta lactam drugs may be sensitizing agents. Cross-contamination can cause drug-induced hypersensitivity reactions in patients, including life-threatening ...

FDA has released Guidance for Industry: Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination.In the guidance, FDA stresses the importance of implementing manufacturing ...

Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound, sending the ...

Among patients with methicillin-susceptible Staphylococcus aureus bloodstream infections, the risk of death in 30 days is lower with beta-lactam therapy than with vancomycin, 45 and a higher rate ...

(Reuters) -Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound ...